Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 2,764 | 2,543 | 3,541 | 3,044 | 5,829 |
| Operating Income | -2,764 | -2,543 | -3,541 | -3,044 | -5,829 |
| Other Income | 21 | 21 | 23 | 29 | 34 |
| Pre-tax Income | -2,743 | -2,522 | -3,518 | -3,015 | -5,795 |
| Net Income Continuous | -2,743 | -2,522 | -3,518 | -3,015 | -5,795 |
| Net Income | $-2,743 | $-2,522 | $-3,518 | $-3,015 | $-5,795 |
| EPS Basic Total Ops | -0.42 | -0.37 | -0.54 | -0.46 | -0.91 |
| EPS Basic Continuous Ops | -0.42 | -0.38 | -0.54 | -0.46 | -0.89 |
| EPS Diluted Total Ops | -0.42 | -0.37 | -0.54 | -0.46 | -0.91 |
| EPS Diluted Continuous Ops | -0.42 | -0.38 | -0.54 | -0.46 | -0.89 |
| EBITDA(a) | $-2,746 | $-2,526 | $-3,528 | $-3,030 | $-5,815 |